⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2737162 | 0.88 | AKT1 (0.33) | — | |
| SCHEMBL12126630 | 0.79 | — | — | |
| SCHEMBL10596394 | 0.76 | — | — | |
| SCHEMBL11115496 | 0.67 | — | — | |
| SCHEMBL215615 | 0.67 | LMNA (0.33) | — | |
| SCHEMBL17269266 | 0.64 | LMNA (0.36) | — | |
| SCHEMBL17269118 | 0.64 | LMNA (0.36) | — | |
| SCHEMBL215748 | 0.64 | AKT1 (0.31) | — | |
| SCHEMBL9571153 | 0.63 | AKT1 (0.39) | — | |
| SCHEMBL23816092 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-3936398-A | 4,7-DIHYDRO-2-ISOPENTYL-2-METHYL-1,3-DIOXEPIN | GIVAUDAN CORPORATION (US) | 1976-02-03 | — | — | US | claimed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS, PBC | 2025-10-09 | — | — | US | disclosed |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| US-20250120427-A1 | CARYOPHYLLENE-CONTAINING COMPOSITION | SUNSHO PHARMACEUTICAL CO., LTD. (JP) | 2025-04-17 | — | — | US | disclosed |
| WO-2025070466-A1 | SEAMLESS CAPSULE FOR ORAL CAVITY | 森下仁丹株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20090270516-A1 | Process for Producing Optically Active Theaspirane | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090087401-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20080293616-A1 | Use of 2-(1,1,4-Trimethylpent-3-Enyl)-4,7-Dihydro-1,3-Dioxepine | SYMRISE GMBH & CO. KG (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | RESONAC CORPORATION (JP) | 2008-04-10 | — | — | US | disclosed |
| US-20060165622-A1 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
| EP-0278020-B1 | 2-SUBSTITUTED 4,4,7,7-TETRAMETHYL-1,3-DIOXACYCLOHEPTANES, THEIR PREPARATION AND USE AS PARFUMES | BASF Aktiengesellschaft (DE) | 1989-05-24 | — | — | EP | disclosed |
| US-3936398-A | 4,7-DIHYDRO-2-ISOPENTYL-2-METHYL-1,3-DIOXEPIN | GIVAUDAN CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |
| US-3936398-A | 4,7-DIHYDRO-2-ISOPENTYL-2-METHYL-1,3-DIOXEPIN | GIVAUDAN CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |